Jose Luis Blanco
Servicio de Enfermedades Infecciosas Médico InternistaGrupo de investigación
- Sida e infección por VIH Accredited researcher (R3A)
Publicaciones destacadas
-
Dual therapy with etravirine plus raltegravir for virologically suppressed infected patients: a pilot study
Autores:Referencia: Journal Of Antimicrobial Chemotherapy 2014. -
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir
Autores:Referencia: Hiv Medicine 2014. -
Acid ceramidase as a therapeutic target in metastatic prostate cancer
Autores:Referencia: Journal Of Lipid Research 2013. -
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function
Autores:Referencia: Journal Of Antimicrobial Chemotherapy 2013. -
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel control studies
Autores:Referencia: Hiv Medicine 2013. -
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Autores:Referencia: Aids 2012. -
COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study
Autores:Referencia: Respiratory Medicine 2011. -
[Current status of acute hepatitis C]
Autores:Referencia: Enfermedades Infecciosas Y Microbiologia Clinica 2011. -
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study
Autores:Referencia: Plos One 2011. -
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area
Autores:Referencia: Hiv Medicine 2007.